A comprehensive view of Prescription Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

VT S0098: An act relating to Green Mountain Care Board authority over prescription drug costs
Published: May 07, 2024 by Vermont 2023-2024 Session
Centers for Medicare & Medicaid Services opens comment period for Inflation Reduction Act's Medicare Drug Price Negotiation Program, which aims to negotiate drug prices from 2026; comments accepted until July 2
Published: May 06, 2024 by The American Hospital Association (AHA)
European Medicines Agency validates Bristol Myers' application for Opdivo nivolumab plus Yervoy ipilimumab for the first-line treatment of adult patients with microsatellite instability–high or mismatch repair deficient metastatic colorectal cancer
Published: May 06, 2024 by Bristol-Myers Squibb Co.
INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "IMMUNOGENIC COMPOSITIONS AGAINST INFLUENZA AND RSV"
Published: May 06, 2024 by U.S. Fed News
LA SB57: Provides relative to the practice of psychology. (8/1/24) (EG +$44,925 SG RV See Note)
Published: May 06, 2024 by Louisiana 2024 Regular Session

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count